SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001079973-24-000295
Filing Date
2024-02-23
Accepted
2024-02-23 16:03:01
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G l1cap_13g.htm SC 13G 31337
  Complete submission text file 0001079973-24-000295.txt   33260
Mailing Address 1177 AVENUE OF THE AMERICAS 5TH FLOOR NEW YORK NY 10036
Business Address 1177 AVENUE OF THE AMERICAS 5TH FLOOR NEW YORK NY 10036 332-216-1147
Sunshine Biopharma, Inc (Subject) CIK: 0001402328 (see all company filings)

IRS No.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-85054 | Film No.: 24671066
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 161A SHEDDEN ROAD ONE ARTILLERY COURT P.O. BOX 10085 GRAND CAYMAN E9 KY1-1001
Business Address 161A SHEDDEN ROAD ONE ARTILLERY COURT P.O. BOX 10085 GRAND CAYMAN E9 KY1-1001 646-688-5654
L1 Capital Global Opportunities Master Fund, Ltd. (Filed by) CIK: 0001702202 (see all company filings)

IRS No.: 981241877 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G